Studying gut bacteria in people with chronic liver disease
Looks at gut bacteria in people with long-lasting liver disease to learn how it develops.
Plain-language title generated from the registry record
Registry title: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Key facts
- Where
- Daejeon, South KoreaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease or liver abscess. People who live with such a patient can also join.
- Age
- 19 years and older
- Sex
- Women and men can join.
Main reasons for not taking part
- People under 19 years of age
- Patients or guardians who do not consent to take part
Read by machine on 12 November 2026.
Where in South Korea
- Chungnam National University HospitaDaejeon, South KoreaContact: HyukSoo EunTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Chungnam National University Hospital
- Trial code
- NCT06519162
- Record updated
- 20 March 2026
- Original description
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.Read full original descriptionShow less
Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Inclusion: Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital; Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital; Exclusion.
Exclusion: Individuals under the age of 19; Patients or guardians who do not consent to participate in the study.